VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AMLXAmylyx Pharmaceuticals, Inc.$13.91$1.2B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAMLXDividend History

AMLX logoAmylyx Pharmaceuticals, Inc. (AMLX) Dividend History

Income profile from 2017 to 2025 with payout safety and yield-on-cost trend

Trailing Dividend / Share
$0.00
0 payments in last 12 months
Dividend Yield
N/A
Current annualized yield
Payout Ratio
N/A
Unknown
Dividend Streak
2 years
Consecutive annual increases
5Y Dividend CAGRN/A
Current Yield on CostN/A
Yield on Cost Trendunknown

AMLX Dividend Income Check

Safety

Payout ratio data not available yet.

Consistency

2 straight years of dividend increases.

Income Trend

Yield on cost trend needs more history.

AMLX Dividend Scorecard

New Dividend2Y streak

Yield & Income

Dividend YieldN/A
Trailing DPS$0.00
FrequencyAnnual
Payments / 12M0

Payout Safety

Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score3/9

Growth

Growth Streak2 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown

Total Returns

Buyback Yield0.0%
Total Shareholder Yield0.0%
1Y Total Return156.6%
5Y Total Return-23.0%
Estimated $10K growth (return + dividends):
5Y ago$7,69810Y ago$8,26220Y ago$8,262

Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.

AMLX Income Growth Story

Dividend per share and yield on cost over time (2 years of payments)

AMLX Dividend Safety Story

EPS is the container — dividend is what's drawn out

Get AMLX's next ex-dividend date and payout in your inbox

Monthly dividend calendar — upcoming ex-dates for stocks you follow.

Free. Unsubscribe any time.

Dividend Analysis

Payout Safety

Amylyx Pharmaceuticals, Inc. has limited earnings payout data (Unknown).

Piotroski F-Score: 3/9 — weak financial health.

Growth Track Record

AMLX has raised its dividend for 2 consecutive years.

Total Shareholder Returns

Beyond cash dividends, AMLX returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.

Income Trend & Total Return

The 5-year total return is -23.0%.

DRIP Growth

A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $8,262 today.

AMLX Recent Dividend Payments

Last 3 payments · Annual

TTM Total$1.02
Avg/Payment$0.3400
Latest Change+16.7%
Ex-DateAmountChangeYield %Payment DateDeclaration DateRecord DateFrequency
Mar 28, 2018Latest$0.4200↑ +16.7%5.64%Apr 2, 2018Jan 25, 2018—Quarterly
Dec 28, 2017$0.3600↑ +50.0%3.32%Jan 2, 2018——Quarterly
Sep 28, 2017$0.2400—1.33%Oct 2, 2017——Quarterly

AMLX Annual Dividend History (2017–2025)

9 years of dividend data

GrowthDecline
YearDPSYoYPmtsEPSPayoutCoverageFCF/ShareFCF PayoutBuyback YldTotal Shld YldYOC
2025$0.00—0$-1.53——$-1.31—0.0%0.0%—
2024$0.00—0$-4.43——$-2.46—0.0%0.0%—
2023$0.00—0$0.70——$0.15—0.0%0.0%—
2022$0.00—0$-2.98——$-2.74—0.0%0.0%—
2021$0.00—0$-1.52——$-1.30————
2020$0.00—0$-0.79——$-0.65————
2019$0.00-100.0%0$-0.26——$-0.19————
2018$0.42-30.0%1———————2.3%
2017$0.60—2———————3.3%

What if you invested $1,000 in AMLX back in 2017?

Total return with dividends reinvested · 9+ years of data

Calculate Returns

How much would $100/month in AMLX be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is AMLX Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

AMLX vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

AMLX — Frequently Asked Questions

Quick answers to the most common questions about buying AMLX stock.

How much dividend does AMLX pay per share?

Amylyx Pharmaceuticals, Inc. (AMLX) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made Annual.

When is AMLX's next ex-dividend date?

AMLX's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. AMLX typically pays dividends Annual.

Is AMLX's dividend safe?

AMLX's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The 2-year growth streak provides moderate confidence.

How many years has AMLX increased its dividend?

AMLX has 2 consecutive years of dividend growth. The 5-year dividend CAGR is N/A.

How often does AMLX pay dividends?

Amylyx Pharmaceuticals, Inc. pays dividends Annual. The trailing 12-month total is N/A per share. Dividend data on this page covers 8+ years from 2017 to 2025.

How much would $10,000 invested in AMLX grow with dividend reinvestment?

With dividends reinvested (DRIP), $10,000 invested in AMLX five years ago would be worth approximately $7,698 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.

What is AMLX's yield on cost for long-term holders?

AMLX's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.